Stockreport

Foghorn Therapeutics appoints Ryan Maynard as CFO [Seeking Alpha]

Tvardi Therapeutics, Inc.  (TVRD) 
PDF Maynard brings over 25 years of executive experience in biopharma and healthcare technology, has raised more than $1 billion in public and private financings, and most [Read more]